This bacteria is getting harder for kids to fight
Obamacare's Surprising HIV Drug Demand
2.5 Billion People Threatened by This Disease: How We're Fighting Back
Cubist and Durata Heat Up Antibiotic Market
Could an Effective Malaria Vaccine Finally Be Within Reach?
CDC Endorses HIV Prevention Drug: Investor Takeaways
1 Stock Fighting the Rise of Deadly Superbugs
The 3 Biggest Biotech Wins of the Week
Alnylam: The Best Hepatitis B Play?
Pfizer Blockbuster Zyvox Under Attack
Ebola Virus Brings Mining to a Halt in West Africa
Why Novavax, Inc. Shares Popped Today
What You Need to Know About Sangamo Biosciences' Surge
This Week in Biotech: Put It in Print
The Ever-Changing Hepatitis C Space
Why Sangamo Biosciences Inc. Shares Surged
Why Would Roche Return to the Antibiotics Market?
An Edge Emerges in the Race to Treat Muscular Dystrophy
Hospitals losing the war on "Superbugs": Your wallet loses, too.